Dyania Health vs Mendel
The two chart abstraction platforms with genuine technical claims behind them, both aimed at the work that has always required a clinician reading a record. Dyania publishes methods rather than claims, has peer reviewed real world evidence from a major academic health system where its platform was embedded in the record system and screened across many hospitals, and it kept the clinician in the loop inside the study itself rather than describing that separately. Mendel makes the sharper architectural argument, pairing language models with symbolic reasoning over a clinical hypergraph specifically because generation alone produces confident errors in abstraction, and it offers the better deployment position, being cloud agnostic and hostable inside your own environment. Both should be asked the same question neither publishes: how often does the system miss an eligible patient, which is the failure that costs a trial.
- Peer reviewed real world evidence at a major academic health system, with the platform embedded in the record system and screening across many hospitals, which very few vendors in this index can show.
- It publishes methods rather than claims, and treated the governance question as a measured endpoint rather than a statement, which is rare engagement anywhere in this index.
- The clinician in the loop design was preserved in the published study itself rather than described separately from it, so the evidence covers the workflow as deployed.
- The architectural claim is specific and motivated by a named failure mode: language models paired with symbolic reasoning over a clinical hypergraph rather than generation alone, which is a real answer to the hallucination problem in chart abstraction.
- It offers the clearest deployment and residency position among these vendors, being cloud agnostic and hostable inside the customer's own environment.
- Diversity was treated as a measured study endpoint in a prospective evaluation at a major academic centre rather than as a marketing claim about equitable access.
Side by Side
| Axis | D Dyania Health |
M Mendel |
|---|---|---|
| AI Centrality | ||
| Autonomy and Oversight Model | ||
| Model and Technology Transparency | ||
| Clinical and Operational Evidence | ||
| AI Safety and PHI Stewardship | ||
| HIPAA and BAA Posture | ||
| Security Certifications and Trust Center | ||
| FDA and Regulatory Status | ||
| AI Governance and Bias Disclosure | ||
| EHR and Interoperability Depth | ||
| Deployment Model and Data Residency | ||
| Commercial Transparency | ||
| Setting and Specialty Coverage |
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Clinical Decision Support page.
Both products read the whole chart to answer specific clinical questions, so the failure that matters is a missed eligible patient rather than a fabricated one, and neither vendor publishes a false negative rate for eligibility screening. Neither publishes a SOC 2, HITRUST or ISO 27001 attestation, and neither has a located trust centre.
Neither publishes pricing, though both frame the economic argument against the cost of clinician chart review, which is the right comparison and should be tested against your own abstraction costs rather than a national average.